Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia

NCT01035671 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Friedreich's Ataxia

Interventions

DRUG: alpha-tocopherolquinone (A0001)
DRUG: alpha-tocopherolquinone (A0001)
DRUG: placebo

Sponsor

Penwest Pharmaceuticals Co.